期刊文献+

108例老年人胃癌的临床分析 被引量:2

下载PDF
导出
摘要 目的:分析与总结老年人胃癌的临床特点和围手术期处理的有关问题。方法:对我院108例老年人胃癌的并存病、术后并发症以及围手术期处理进行分析总结。结果:108例老年人胃癌,80例(74.1%)患者伴有高血压、心脏病、糖尿病、慢性支气管炎、肺气肿等并存病。术后发生并发症共18例,死亡6例。术前有并存病者术后并发症的发生率为26.8%,而手术前无并存病者,术后并发症的发生率为14.5%,两者有非常显著性的差异(P<0.01)。结论:老年人胃癌患者常伴有高血压、心脏病、糖尿病、肺气肿等疾病,加强围手术期处理,选择适当的手术方式可提高手术的安全性,减少并发症的发生,提高生存质量。
作者 谢崇
出处 《现代肿瘤医学》 CAS 2008年第11期1966-1967,共2页 Journal of Modern Oncology
  • 相关文献

参考文献3

二级参考文献1

  • 1Ulrich Keller M.D.,Didier Clerc M.D.,Marius Kr?nzlin M.D.,M. Heberer M.D.. Protein-sparing therapy in the postoperative period[J] 1986,World Journal of Surgery(1):12~19

共引文献109

同被引文献19

  • 1赵如森,崔玉中.小剂量化疗治疗高龄晚期胃癌患者疗效观察[J].中外健康文摘:临床医师,2008,0(4):20-21. 被引量:3
  • 2Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 3Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol,1997,15(6):2403-2413.
  • 4Murad AM,Santiago FF,Petroianu A,et al.Modified therapy with 5-fluorouracil,doxorubicin,and methotrexate in advanced gastric cancer[J].Cancer,1993,72:37-41.
  • 5Pyrhonen S,Kuitunen T,Nyandoto P,et al.Randomised comparison of fluorouracil,epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer[J].Br J Cancer,1995,71:587-591.
  • 6Ohtsu A,Shimada Y,Shirao K,et al.Randomized phase Ⅲ trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer:The Japan Clinical Oncology Group Study (JCOG9205)[J].J Clin Oncol,2003,21:54-59.
  • 7Waters JS,Norman A,Cunningham D,et al.Long-term survival after epirubicin,cisplatin and fluorouracil for gastric cancer:results of a randomized trial[J].Br J Cancer,1999,80:269-272.
  • 8Lim JY,Cho JY,Oh KJ,et al.Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma[J].Chemotherapy,2009,55(4):200-206.
  • 9Trumper M,Ross PJ,Cunningham D,et al.Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer:A pooled analysis of three clinical trials[J].Eur J Cancer,2006,42(7):827-834.
  • 10Cavanna A,Zaniboni F,Artioli A.Oxaliplatin (OXA),5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC)[J].J Clin Oncol,ASCO Annual Meeting Proceedings (Post-Meeting Edition),2004,22:4068.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部